FDx Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,040
| Closed | -$251K | – | 828 |
|
|
2023
Q1 | $251K | Hold |
7,040
| – | – | 0.01% | 634 |
|
|
2022
Q4 | $251K | Sell |
7,040
-211
| -3% | -$7.52K | 0.01% | 634 |
|
|
2022
Q3 | $245K | Sell |
7,251
-388
| -5% | -$13.1K | 0.01% | 620 |
|
|
2022
Q2 | $221K | Sell |
7,639
-127
| -2% | -$3.67K | 0.01% | 742 |
|
|
2022
Q1 | $251K | Buy |
7,766
+733
| +10% | +$23.7K | 0.01% | 723 |
|
|
2021
Q4 | $205K | Buy |
+7,033
| New | +$205K | 0.01% | 827 |
|
|
2018
Q1 | – | Sell |
-5,544
| Closed | -$221K | – | 1256 |
|
|
2017
Q4 | $221K | Buy |
5,544
+53
| +1% | +$2.11K | 0.01% | 1160 |
|
|
2017
Q3 | $220K | Sell |
5,491
-548
| -9% | -$22K | 0.01% | 1177 |
|
|
2017
Q2 | $260K | Buy |
+6,039
| New | +$260K | 0.01% | 1038 |
|